The approval was based on results from the TROPION-Breast01 Phase III trial.

Trenchant BioSystems Inc., a CGT manufacturing platform developer for gene-modified cells, and Autolomous, a cloud-based, ...

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...

Aims to enhance RNA production technologies with the goal of a continuous manufacturing platform and advancement of PAT.

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief Executive Officer (CEO), effective immediately.

Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

Touchlight’s facility in Hampton, UK has received GMP certification, making the CDMO the first synthetic DNA manufacturer ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...